Compare peptides side by side
Overlay effect profiles, evidence grades and pharmacokinetics for two to four peptides. Every comparison is built from the same indexed studies as the individual profiles — no editorial ranking, no sponsored placement.
Build a custom comparison
Pick two to four. 146 peptides available.What each comparison shows
Seven axes, overlaid. Shape difference is the fastest read on whether two peptides are really alternatives.
Grade A–D from the study mix — human, animal, cellular, trial phase — not from popularity.
Half-life, route, time to peak, and the basis for each figure. Unknowns stay em-dashes.
How many indexed studies sit behind each, and how recent the newest one is.
A per-goal decision matrix, generated from category leaders rather than written by hand.
Most-searched comparisons
Where the traffic actually goes.Grade B vs A · 25 and 57 indexed studies.
Both grade B · 14 and 9 indexed studies.
Grade A vs B · 23 and 25 indexed studies.
Grade B vs A · 19 and 14 indexed studies.
Grade B vs A · 6 and 14 indexed studies.
Both grade A · 57 and 22 indexed studies.
Grade B vs A · 22 and 13 indexed studies.
Grade A vs B · 11 and 6 indexed studies.
GLP-1 & weight loss
Approved agents and the compounds sold alongside them.Growth-hormone secretagogues
Different receptors, very different half-lives.Healing & tissue repair
The busiest cluster, and the thinnest human evidence.Nootropics & cognition
Most trial data published outside Western indexes.Longevity, metabolic & other
Long horizons, short evidence.Comparisons describe published research, not suitability. A higher grade means more evidence exists, not that a compound is safe or appropriate for anyone. Not medical advice.